Provencio Pulla, M., Ortega Granados, A. L., Coves-Sarto, J., Calvo, V., Marsé-Fabregat, R., Dómine Gómez, M., . . . Cruz-Bermúdez, A. (2023). Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden.
Citación estilo ChicagoProvencio Pulla, Mariano|||0000-0001-6315-7919, et al. Atezolizumab Plus Bevacizumab As First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden. 2023.
Cita MLAProvencio Pulla, Mariano|||0000-0001-6315-7919, et al. Atezolizumab Plus Bevacizumab As First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden. 2023.